Sarcoma Drugs Market is anticipated to expand from $1.7 billion in 2024 to $4.8 billion by 2034, growing at a CAGR of approximately 11.6%.
Market Overview The Sarcoma Drugs Market is undergoing a period of accelerated evolution as innovations in oncology reshape treatment pathways for rare cancers. Sarcoma, which …